Pancreatic Cancer Research

ResearcherHarold C. Simmons Comprehensive Cancer CenterActive in the last 2 years

Nina Niu Sanford

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7840-5700; OpenAlex author ID A5009289831. Sources: OpenAlex.

Their work

Papers
13 (first author 3, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
54
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 4 papers · 2023: none · 2024: 1 paper · 2025: 5 papers · 2026: 1 paper

Papers 13

  1. Radiation Therapy for Pancreatic Cancer: An ASTRO Clinical Practice Guideline. Co-author DOI 10.1016/j.prro.2026.07.002↗
  2. Controversies in upper gastrointestinal cancers-the role of radiotherapy in borderline resectable pancreatic cancer. First author DOI 10.1016/j.esmogo.2025.100232↗
  3. NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation Therapy. Co-author DOI 10.1016/j.ijrobp.2024.10.026↗
  4. Definitive Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer: Historical Review, Current State and Future Directions. First author DOI 10.1016/j.semradonc.2025.07.002↗
  5. Post-operative patterns of failure and outcomes reveal opportunities to optimize treatment of recurrent pancreatic cancer Co-author DOI 10.1101/2025.11.08.25339815↗
  6. Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-24-3582↗
  7. Ablative treatments for locally advanced pancreatic cancer: the CROSSFIRE trial. First author DOI 10.1016/s2468-1253(24)00130-4↗
  8. Measuring the Effect of Local Control From Radiotherapy in Patients With Pancreatic Adenocarcinoma. Co-author DOI 10.1001/jamaoncol.2021.7037↗
  9. Radiotherapy for Pancreatic Adenocarcinoma: Recent Developments and Advances on the Horizon. Last author DOI 10.1016/j.hoc.2022.06.002↗
  10. Elective Target Coverage for Pancreatic Cancer: When Less Does Not Clearly Achieve More. Last author DOI 10.1016/j.ijrobp.2021.08.024↗
  11. Ablative Radiation Therapy in Oligometastatic Pancreatic Cancer to Delay Polyprogression, Limit Chemotherapy, and Improve Outcomes. Co-author DOI 10.1016/j.ijrobp.2022.07.019↗
  12. Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer. Co-author DOI 10.1097/coc.0000000000000802↗
  13. Sociodemographic Disparities in the Receipt of Adjuvant Chemotherapy Among Patients With Resected Stage I-III Pancreatic Adenocarcinoma. Co-author DOI 10.6004/jnccn.2019.7322↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Todd Anthony Aguilera · 5 shared papers, 2019–2025 · strength 0.83
  2. Michael David Chuong · 3 shared papers, 2022–2026 · strength 0.67
  3. Syed Mohammad Ali Kazmi · 4 shared papers, 2021–2025 · strength 0.66
  4. Herbert J. Zeh · 4 shared papers, 2019–2025 · strength 0.64
  5. William Adrian Hall · 2 shared papers, 2024–2025 · strength 0.55
  6. Patricio Marcelo Polanco · 3 shared papers, 2022–2025 · strength 0.54
  7. Ahmed M. Elamir · 3 shared papers, 2022–2025 · strength 0.54
  8. Matthew R. Porembka · 3 shared papers, 2022–2025 · strength 0.54
  9. Anjalika R. Kumar · 1 shared paper, 2025 · strength 0.54
  10. Muhammad Shaalan Beg · 4 shared papers, 2019–2025 · strength 0.53
  11. Theodore Sunki Hong · 2 shared papers, 2022–2025 · strength 0.45
  12. Jeroen Dekervel · 1 shared paper, 2025 · strength 0.42
  13. Bas Groot Koerkamp · 1 shared paper, 2025 · strength 0.42
  14. Michael Frederick Bassetti · 2 shared papers, 2025–2026 · strength 0.41
  15. Marsha Reyngold · 2 shared papers, 2025–2026 · strength 0.41
  16. Karyn A. Goodman · 2 shared papers, 2025–2026 · strength 0.41
  17. Amol Kumar Narang · 2 shared papers, 2025–2026 · strength 0.41
  18. Peter Q. Leung · 2 shared papers, 2025 · strength 0.41
  19. Salwan S. Al Mutar · 2 shared papers, 2025 · strength 0.41
  20. Jasmijn Maria Westerhoff · 1 shared paper, 2024 · strength 0.36
  21. John C. Mansour · 2 shared papers, 2019–2025 · strength 0.28
  22. Jordan R. Kharofa · 1 shared paper, 2022 · strength 0.26
  23. John Michael P. Tomagan · 1 shared paper, 2025 · strength 0.23
  24. Shahed Nicolas Badiyan · 1 shared paper, 2025 · strength 0.23
  25. Rachna T. Shroff · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.